12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant movement in Friday's after-market session. Bellerophon Therapeutics, Cingulate, Rain Oncology, Artelo Biosciences, Processa Pharma, and Eiger BioPharmaceuticals saw gains, while Eloxx Pharmaceuticals, TRACON Pharma, Universe Pharmaceuticals, Purple Biotech, RVL Pharmaceuticals, and OpGen experienced losses.

October 13, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Artelo Biosciences shares rose 9.72% to $1.58.
The rise in Artelo Biosciences' share price suggests positive investor sentiment, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Bellerophon Therapeutics stock moved upwards by 17.1% to $0.12 during Friday's after-market session.
The significant increase in Bellerophon Therapeutics' stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Cingulate stock increased by 12.59% to $0.58.
The increase in Cingulate's stock price suggests positive investor sentiment, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Eiger BioPharmaceuticals stock rose 7.78% to $0.27.
The rise in Eiger BioPharmaceuticals' stock price suggests positive investor sentiment, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Processa Pharma shares moved upwards by 8.37% to $0.52.
The upward movement in Processa Pharma's share price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Rain Oncology stock rose 11.11% to $1.1.
The rise in Rain Oncology's stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Eloxx Pharmaceuticals stock decreased by 17.5% to $3.15 during Friday's after-market session.
The significant decrease in Eloxx Pharmaceuticals' stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
OpGen shares declined by 6.16% to $0.77.
The decline in OpGen's share price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Purple Biotech shares fell 6.26% to $1.2.
The fall in Purple Biotech's share price suggests negative investor sentiment, potentially leading to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
RVL Pharmaceuticals stock declined by 6.17% to $0.07.
The decline in RVL Pharmaceuticals' stock price suggests negative investor sentiment, potentially leading to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
TRACON Pharma stock declined by 7.66% to $0.18.
The decline in TRACON Pharma's stock price suggests negative investor sentiment, potentially leading to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Universe Pharmaceuticals stock declined by 7.41% to $1.0.
The decline in Universe Pharmaceuticals' stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100